Metastatic RET-Rearranged Lung Adenocarcinomas Treated with Alectinib: Retrospective Analysis of a Single Institution

被引：0
|
作者：
Ribeiro, M. [1 ]
Gongora, A. [1 ]
Oliveira, L. [1 ]
Alessi, J. V. [1 ]
Saccardo, K. [1 ]
Zucchetti, B. [1 ]
Barbosa, F. [1 ]
Muniz, D. [1 ]
Shimada, A. [1 ]
De Souza, C. [1 ]
Feher, O. [1 ]
Katz, A. [1 ]
机构：
[1] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
alectinib; RET-rearranged;
D O I：
10.1016/j.jtho.2019.08.1852
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-67
引用
收藏
页码：S857 / S858
页数：2
相关论文
共 50 条
  • [1] Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer
    Lin, Jessica J.
    Kennedy, Elizabeth
    Sequist, Lecia V.
    Brastianos, Priscilla K.
    Goodwin, Kelly E.
    Stevens, Sara
    Wanat, Alexandra C.
    Stober, Lisa L.
    Digumarthy, Subba R.
    Engelman, Jeffrey A.
    Shaw, Alice T.
    Gainor, Justin F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 2027 - 2032
  • [2] Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series
    Silva Almeida Ribeiro, Mauricio Fernando
    Machado Alessi, Joao Victor
    Carvalho Oliveira, Leandro Jonata
    Lara Gongora, Aline Bobato
    Sacardo, Karina Perez
    Zucchetti, Bruna Migliavacca
    Shimada, Andrea Kazumi
    Barbosa, Felipe de Galiza
    Feher, Olavo
    Katz, Artur
    LUNG CANCER, 2020, 139 : 9 - 12
  • [3] RET-Rearranged Lung Adenocarcinomas with Lymphangitic Spread, Psammoma Bodies, and Clinical Responses to Cabozantinib
    Mukhopadhyay, Sanjay
    Pennell, Nathan A.
    Ali, Siraj M.
    Ross, Jeffrey S.
    Ma, Patrick C.
    Velcheti, Vamsidhar
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1714 - 1719
  • [4] Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial
    Felip, Enriqueta
    Smit, Egbert F.
    Molina-Vila, Miguel A.
    Dafni, Urania
    Massuti, Bartomeu
    Berghmans, Thierry
    de Marinis, Filippo
    Passiglia, Francesco
    Dingemans, Anne-Marie C.
    Cobo, Manuel
    Viteri, Santiago
    Britschgi, Christian
    Cuffe, Sinead
    Provencio, Mariano
    Merkelbach-Bruse, Sabine
    Andriakopoulou, Charitini
    Kammler, Roswitha
    Ruepp, Barbara
    Roschitzki-Voser, Heidi
    Peters, Solange
    Wolf, Juergen
    Stahel, Rolf
    LUNG CANCER, 2022, 172 : 94 - 99
  • [5] Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)
    Takeuchi, Shinji
    Yanagitani, Noriko
    Seto, Takashi
    Hattori, Yoshihiro
    Ohashi, Kadoaki
    Morise, Masahiro
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Goto, Koichi
    Nishio, Makoto
    Takahara, Shizuko
    Kawakami, Takahiro
    Imai, Yasuhito
    Yoshimura, Kenichi
    Tanimoto, Azusa
    Nishiyama, Akihiro
    Murayama, Toshinori
    Yano, Seiji
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 314 - 325
  • [6] Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET)
    Yanagitani, N.
    Takeuchi, S.
    Murayama, T.
    Yoshimura, K.
    Imai, Y.
    Takahara, S.
    Kawakami, T.
    Seto, T.
    Hattori, Y.
    Ohashi, K.
    Morise, M.
    Matsumoto, S.
    Yoh, K.
    Goto, K.
    Nishio, M.
    Yano, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S207 - S207
  • [7] RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome
    Abbar, Baptiste
    Henry, Carole
    Theou-Anton, Nathalie
    Brosseau, Solenn
    Nguenang, Marina
    Pluvy, Johan
    Assoun, Sandra
    Zalcman, Gerard
    Gounant, Valerie
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : E250 - E251
  • [8] Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers
    Offin, Michael
    Guo, Robin
    Wu, Stephanie L.
    Sabari, Joshua
    Land, Josiah D.
    Ni, Ai
    Montecalvo, Joseph
    Halpenny, Darragh F.
    Buie, Larry W.
    Pak, Terry
    Liu, Dazhi
    Riely, Gregory J.
    Hellmann, Matthew D.
    Benayed, Ryma
    Arcila, Maria
    Kris, Mark G.
    Rudin, Charles M.
    Li, Bob T.
    Ladanyi, Marc
    Rekhtman, Natasha
    Drilon, Alexander
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 8
  • [9] Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non-Small Cell Lung Cancer
    Kodama, Tatsushi
    Tsukaguchi, Toshiyuki
    Satoh, Yasuko
    Yoshida, Miyuki
    Watanabe, Yoshiaki
    Kondoh, Osamu
    Sakamoto, Hiroshi
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2910 - 2918
  • [10] Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (06) : 797 - 800
12345